Clinical trial NCT03996902: Increasing Cessation Motivation and Treatment Engagement Among Smokers in Pain
Official title: Increasing Cessation Motivation and Treatment Engagement Among Smokers in Pain
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Chronic Pain
Smoking
Smoking Cessation
Keywords: Chronic Pain
Tobacco
Smoking
Smoking cessation
Motivation
Lead sponsor: Syracuse University
Sponsor class: OTHER
Collaborators: name: National Institute on Drug Abuse (NIDA)
First posted: 2019-06-25
Enrollment: 76
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: BASIC_SCIENCE

Brief summary: The goal of this study is to develop and pilot test a brief intervention to increase motivation to quit and smoking cessation treatment engagement among smokers with chronic pain.

Detailed description: Pain and tobacco smoking are both critical national health problems, and there is mounting evidence that smokers in pain may represent an important and large subgroup who experience unique barriers and greater difficulty quitting. Smoking has been identified as a risk factor in the onset and exacerbation of chronic pain, and smokers experience greater levels of pain intensity and disability, relative to non-smokers. Initial evidence indicates that quitting smoking may improve pain outcomes (e.g., lower pain intensity) and supports the notion that smoking cessation may be an essential behavior change for smokers in pain. However, the vast majority of smokers are not yet ready to engage a serious quit attempt, and evidence-based treatments for smoking cessation remain dramatically underutilized. Therefore, the goal of this study is to develop and pilot test a brief intervention that will address smoking in the context of pain in order to increase motivation to quit smoking and engagement of available smoking cessation treatment. Participants will be randomized to either the adapted brief motivational intervention or an intervention consistent with standard clinical practice

Eligibility criteria: Inclusion Criteria:

* Current daily cigarette smoking (at least 10/day)
* Current moderate-very sever chronic pain with a numerical pain rating of at least 4/10
* At least 18 years of age

Exclusion Criteria:

* Current active attempt to quit smoking
* Enrollment in smoking cessation treatment or use of a smoking cessation medication
* Less than 18 years of age

Primary outcomes:
measure: Motivation to Quit Smoking
timeFrame: 30 days
measure: Motivation to engage cessation treatment
timeFrame: 30 days
measure: Knowledge of pain-smoking interrelations
timeFrame: 30 days
Secondary outcomes:
measure: Smoking behavior
timeFrame: 30 days
measure: Use of cessation treatment
timeFrame: 30 days
Other outcomes:
Locations:
city: Syracuse
country: United States
facility: Joseph Ditre
state: New York
Study officials:
affiliation: Syracuse University
name: Emily Zale, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Zale EL, Maisto SA, De Vita MJ, Hooten WM, Ditre JW. Increasing cessation motivation and treatment engagement among smokers in pain: A pilot randomized controlled trial. Exp Clin Psychopharmacol. 2021 Dec;29(6):593-604. doi: 10.1037/pha0000424. Epub 2020 Aug 6.